Showing results (191-200 of 321) with videos related to
Sort By:
Pageof 33
Circulation|June 1, 1993
Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies GroupG Johnson, P Carson, G S Francis, et al.The American Journal of Physiology|October 1, 1980
Progressive myocardial dysfunction associated with increased vascular resistanceJ A Franciosa, R Heckel, C Limas, et al.The American Journal of Cardiology|September 15, 1996
Effects of long-term cigarette smoking on endothelium-dependent responses in humansG E McVeigh, L Lemay, D Morgan, et al.The American Journal of Cardiology|August 1, 1975
Hemodynamic effect of dobutamine in patients with severe heart failureN Akhtar, E Mikulic, J N Cohn, et al.Clinical Pharmacology and Therapeutics|October 1, 1983
Increased renal plasma flow in long-term enalapril treatment of hypertensionG Simon, S Morioka, D K Snyder, et al.Circulation|June 1, 1993
Influence of age on mechanisms and prognosis of heart failure. The V-HeFT VA Cooperative Studies GroupC V Hughes, M Wong, G Johnson, et al.Circulation|November 1, 1978
Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failureC Curtiss, J N Cohn, T Vrobel, et al.Journal of Cardiovascular Pharmacology|August 1, 1990
Cardiovascular and neurohormonal effects of atrial natriuretic peptide in conscious dogs with and without chronic left ventricular dysfunctionP Carson, P Carlyle, T S Rector, et al.The American Journal of Cardiology|January 19, 1995
Pathophysiologic aspects of end-stage heart failureG S Francis, K McDonald, C Chu, et al.The American Journal of Cardiology|October 22, 1979
Role of vasoconstrictor mechanisms in the control of left ventricular performance of the normal and damaged heartJ N Cohn, I Mashiro, T B Levine, et al.Pageof 33